Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Elevated plasma TGF-beta1 in renal diseases: cause or consequence?

U Junker1, C C Haufe, K Nuske

  • 1Institute of Clinical Immunology, Friedrich-Schiller-University, Jena, Germany. iuj@RZ.Uni-Jena.De

Cytokine
|July 6, 2000
PubMed
Summary

Elevated plasma transforming growth factor-beta1 (TGF-beta1) is linked to chronic kidney disease and renal cell carcinoma. Levels normalize after kidney transplantation, suggesting TGF-beta1

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Helminth parasites of impalas, <i>Aepyceros melampus</i>, in eastern southern Africa, collected during 1973 to 2007.

Journal of the South African Veterinary Association·2024
Same author

Major trauma in Older Adults - a retrospective analysis of the Major Trauma Audit.

Irish medical journal·2024
Same author

Development and inter-laboratory validation of the VISAGE enhanced tool for age estimation from semen using quantitative DNA methylation analysis.

Forensic science international. Genetics·2021
Same author

MiR-205-driven downregulation of cholesterol biosynthesis through SQLE-inhibition identifies therapeutic vulnerability in aggressive prostate cancer.

Nature communications·2021
Same author

[Right upper abdominal pain, vomiting, weight loss and icterus in a 20-year-old male refugee].

Der Internist·2020
Same author

Nematodes and cestodes of rodents in South Africa: baseline data on diversity and geographic distribution.

Journal of helminthology·2019

Area of Science:

  • Nephrology
  • Oncology
  • Immunology

Background:

  • Previous studies reported elevated transforming growth factor-beta1 (TGF-beta1) in renal carcinoma patients.
  • The role of chronic kidney damage in TGF-beta1 elevation remained unclear.

Purpose of the Study:

  • To investigate plasma and serum TGF-beta1 levels in patients with various renal diseases, lung cancer, and humoral immunodeficiency.
  • To determine if chronic kidney damage contributes to elevated TGF-beta1 and its potential link to renal cancer development.

Main Methods:

  • Measurement of latent and active TGF-beta1 in plasma and serum.
  • Patient groups included controls, pyelonephritis, chronic extracorporeal dialysis, renal cell carcinoma, lung cancer, immunodeficiency, and kidney transplant recipients.
  • Comparison of TGF-beta1 levels before and after interventions like extracorporeal lithotripsy and kidney cancer surgery.

Related Experiment Videos

Main Results:

  • Plasma TGF-beta1 levels were significantly elevated in pyelonephritis (19.0 ng/ml), chronic dialysis (15.5 ng/ml), and renal cell carcinoma (22.8 ng/ml) patients compared to controls (7.0-8.8 ng/ml).
  • Acute renal stress did not increase TGF-beta1. Serum TGF-beta1 was elevated only in renal carcinoma patients.
  • Kidney transplantation normalized TGF-beta1 levels; surgery partially reduced levels in cancer patients.

Conclusions:

  • Elevated plasma TGF-beta1 is common in chronic kidney disease and renal cell carcinoma.
  • Restoration of renal function, such as through transplantation, normalizes TGF-beta1 levels.
  • Chronic TGF-beta1 elevation may predispose to renal cancer in patients with chronic kidney conditions.